Cellebrite
CLBT
199 hedge funds and large institutions have $2.16B invested in Cellebrite in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 70 increasing their positions, 68 reducing their positions, and 32 closing their positions.
209% more call options, than puts
Call options by funds: $6.34M | Put options by funds: $2.05M
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
4% more funds holding
Funds holding: 191 → 199 (+8)
3% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 68
6.23% less ownership
Funds ownership: 52.68% → 46.45% (-6.2%)
11% less capital invested
Capital invested by funds: $2.42B → $2.16B (-$254M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$66M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$38.1M |
| 3 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$28.2M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$26.7M |
| 5 |
Bank of New York Mellon
New York
|
+$24.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$33.8M |
| 2 |
Morgan Stanley
New York
|
-$25.2M |
| 3 |
CPM
Crescent Park Management
East Palo Alto,
California
|
-$24.8M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$22.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$18.2M |
CLBT Hedge Fund Activity: Q1 2025 in Review
199 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q1 2025, worth a combined $2.16B — down 11% from $2.42B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CLBT positions and 32 closed out — a net gain of 11 holders — while 70 added to existing stakes and 68 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $66M. The largest seller was Nine Ten Capital Management, cutting an estimated $33.8M.
- 199 institutional investors held Cellebrite (CLBT) as of Q1 2025, up from 191 in Q4 2024.
- Funds reported $2.16B of Cellebrite stock for Q1 2025, down 11% quarter-over-quarter.
- 43 funds opened new Cellebrite positions in Q1 2025 and 32 closed out, a net change of +11 holders.
- The largest Cellebrite buyer in Q1 2025 was T. Rowe Price Investment Management, an estimated $66M added.
- The largest Cellebrite seller in Q1 2025 was Nine Ten Capital Management, an estimated $33.8M sold.
Based on aggregated 13F filings for Q1 2025.